Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors

DUBLIN, June 24, 2013 /PRNewswire/ --

Research and Markets ( http://www.researchandmarkets.com/research/55dz4h/competitor) has announced the addition of the "Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The new Competitive Intelligence Report Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis in the product portfolios and development pipelines of ten major classes of therapeutic proteins and their biosimilar and biobetter/biosuperior versions in regulated and less regulated markets:

- Erythropoietin (EPO) & Erythr
- G-CSF & GM-CSF
- Thrombopoietin & Thrombopoies
- Interferon
- Insulin
- Coagulation Factors
- Human Growth Hormone (hGH)
- FSH, hCG and LH: Therapeutic
- Thrombolytics & Fibrinolytics
- Enzyme Replacement Therapies

Territories covered are the major pharmaceutical markets North America, Europe and Japan, as well as South Korea, India, China and other countries in Latin America, Africa and Australasia.

With more than US$ 50 bln in sales, therapeutic proteins represent a major category of pharmaceutical products with established therapeutic value and high economic attractiveness. As more and more of the branded products are running out of patent protection and regulatory agencies are providing better guidance, development of biosimilar versions as well as of improved next generation versions are a highly attractive goal for pharmaceutical and biotechnology as well as technology focused companies.

This report includes a compilation of current active projects in research and development of biosimilar and novel biobetter/biosuperior therapeutic proteins as well as non-protein based competitor products and an overview of approved products in regulated and less regulated markets.

Competitor projects are listed in a tabular format providing Information on:

- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Company,
- Product Category,
- Indication,
- R&D Stage,
- additional comments with a hyperlink leading to the source of information.


For more information visit http://www.researchandmarkets.com/research/55dz4h/competitor

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals